HomepageAMBBY • OTCMKTS
add
Ambu
Vorige slotkoers
$Â 18,54
Jaar-range
$Â 13,02 - $Â 22,65
Beurswaarde
31,97Â mld. DKK
Gem. volume
141,00
Marktnieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
| (DKK) | sep 2024info | Wijziging j-o-j |
|---|---|---|
Opbrengst | 1,39Â mld. | 10,17% |
Bedrijfskosten | 670,00Â mln. | 8,41% |
Netto inkomsten | -135,00Â mln. | -268,75% |
Netto winstmarge | -9,73 | -253,23% |
Winst per aandeel | 0,43 | 35,57% |
EBITDA | 242,00Â mln. | 78,60% |
Effectief belastingtarief | 25,41% | — |
Balans
Totale activa
Totale passiva
| (DKK) | sep 2024info | Wijziging j-o-j |
|---|---|---|
Contanten en kortetermijnbeleggingen | 615,00Â mln. | 291,72% |
Totale activa | 7,15Â mld. | 4,30% |
Totale passiva | 1,56Â mld. | 6,41% |
Totaal aandelenvermogen | 5,59 mld. | — |
Uitstaande aandelen | 266,39 mln. | — |
Koers-boekwaardeverhouding | 0,88 | — |
Rendement op activa | 5,09% | — |
Rendement op kapitaal | 5,87% | — |
Kasstroom
Nettomutatie in liquide middelen
| (DKK) | sep 2024info | Wijziging j-o-j |
|---|---|---|
Netto inkomsten | -135,00Â mln. | -268,75% |
Operationele kasstroom | 193,00Â mln. | -29,30% |
Kasstroom uit beleggingen | -95,00Â mln. | -11,76% |
Kasstroom uit financiering | -18,00Â mln. | 89,71% |
Nettomutatie in liquide middelen | 81,00Â mln. | 523,08% |
Vrije kasstroom | 100,88Â mln. | -5,39% |
Over
Ambu, or officially Ambu A/S, is a Danish company that develops, produces and markets single-use endoscopy solutions, diagnostic and life-supporting equipment to hospitals, private practices, and rescue services.
It was founded in Denmark in 1937, as Testa Laboratorium, by German engineer Holger Hesse.
The largest business areas are anesthesia, cardiology, neurology, pulmonology, urology and gastroenterology. The company's most important products are devices for artificial ventilation, single-use endoscopes and single-use electrodes for ECG tests and neurophysiological mappings. Wikipedia
Opgericht
1937
Website
Werknemers
5.196
